- Home
- FLNG vs XGN Comparison
FLNG vs XGN Comparison
Compare FLNG & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNG | XGN |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 74.6M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLNG | XGN |
|---|---|---|
| Price | $29.77 | $2.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $23.00 | $9.14 |
| AVG Volume (30 Days) | ★ 831.5K | 328.2K |
| Earning Date | 02-11-2026 | 03-10-2026 |
| Dividend Yield | ★ 9.97% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.51 |
| Revenue Next Year | $2.14 | $13.23 |
| P/E Ratio | $19.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.46 | $2.75 |
| 52 Week High | $31.99 | $12.23 |
Technical Indicators
Market Signals| Indicator | FLNG | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 31.05 |
| Support Level | $24.54 | N/A |
| Resistance Level | $30.58 | $3.89 |
| Average True Range (ATR) | 0.98 | 0.28 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 41.23 | 11.09 |
Price Performance
Historical ComparisonAbout FLNG FLEX LNG Ltd.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The company's fleet consists of several LNG carriers on the water, and all of its vessels are of the latest generation equipped with two-stroke propulsion. Its fleet consists of M-type, Electronically Controlled, Gas Injection (MEGI) LNG carriers and Generation X Dual Fuel (X-DF) LNG carriers, offering improvements in fuel efficiency and thus also carbon footprint compared to the older steam and four-stroke propelled ships. The company has one reportable segment: vessel operations, which generates revenue from the chartering of vessels to customers.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.